Literature DB >> 30392299

[2017 ENETS consensus guidelines: update for the standard of care of pancreatic neuroendocrine tumors].

H L Gao1, L Liu, W Q Wang, X J Yu.   

Abstract

Neuroendocrine tumors(NET) is a rare tumor with high heterogeneity.Pancreatic NET is the most common type in China. European Neuroendocrine Tumor Society(ENETS) has launched the ENETS guidelines since 2006 and published the ENETS standard of care in 2009. With the newly targeted therapies and further research on NET, 2017 new edition of the ENETS standard of care has changed a lot in the diagnosis and treatment of NET. This article explains the update of pancreatic NET in the 2017 edition of the ENETS standard of care, and introduces pancreatic NET from pathology, imaging examination, surgery, systemic therapy, etc., and deepens the understanding of the diagnosis and treatment of pancreatic NET.

Entities:  

Keywords:  Neuroendocrine tumors; Pancreatic neoplasms; Treatment

Mesh:

Year:  2018        PMID: 30392299     DOI: 10.3760/cma.j.issn.0529-5815.2018.11.003

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  1 in total

1.  Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors.

Authors:  Taymeyah Al-Toubah; Brian Morse; Jonathan Strosberg
Journal:  Curr Oncol       Date:  2022-01-26       Impact factor: 3.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.